
Clinical study · PLOS ONE, 2018
83%±
average reduction in surface pathogens
Six hospitals, 11,842 patients, 24,875 environmental samples. Probiotic-based sanitation was associated with a mean 83% decrease in surface pathogens (range 70–96.3%), and healthcare-associated infection incidence fell from 4.8% to 2.3%.
Caselli E, et al. · Setting: Six hospitals, probiotic-based cleaning products

Clinical study · Infection and Drug Resistance, 2019
99%±
reduction in antimicrobial-resistance genes, at most
Five hospitals, six months per sanitation type. Probiotic sanitation was associated with up to a 99% decrease in resistance genes in surface microbiota and a 33–100% decrease in resistant strains depending on the antibiotic; antimicrobial drug use tied to infections fell 60.3%.
Caselli E, et al. · Setting: Five hospitals, probiotic-based cleaning products

Laboratory study · MicrobiologyOpen, 2023
97.7%±
prevention of dry biofilm formation in the lab
A Bacillus-based probiotic cleanser prevented over 97.7% of dry biofilm formation by E. coli and S. aureus across steel, ceramic and melamine surfaces. Microscopy showed the probiotic bacteria germinating and colonising the surfaces, likely forming a protective layer.
Wormald R, et al. · Setting: Laboratory surfaces, a Bacillus-based probiotic cleanser